ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,672Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 3647

$673K Total Retail Price of All Prescriptions

Rank: 616 out of 3647

871 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 871 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 871 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 1,077 1,064 1 5
LISINOPRIL 1,010 993 2 4
OMEPRAZOLE 951 943 3 3
AMLODIPINE BESYLATE 946 916 4 2
SIMVASTATIN 919 885 5 1
METOPROLOL TARTRATE 864 836 6 7
FUROSEMIDE 586 574 7 8
LOVASTATIN 530 526 8 21
WARFARIN SODIUM 513 513 9 15
TEMAZEPAM 496 488 10 47
ATENOLOL 483 479 11 10
METFORMIN HCL 391 384 12 6
ALLOPURINOL 371 365 13 37
CLONIDINE HCL 360 360 14 46
DIGOXIN 325 325 15 51
ALPRAZOLAM 299 283 16 31
GLYBURIDE 289 283 R 17 54
SERTRALINE HCL 268 249 18 27
HYDROCODONE-ACETAMINOPHEN 254 240 S3 19 12
NIFEDIPINE ER 246 246 20 67
POTASSIUM CHLORIDE 238 238 21 24
DONEPEZIL HCL 228 228 22 30
CARVEDILOL 202 202 23 20
TRIAMTERENE-HCTZ 192 192 24 58
TAMSULOSIN HCL 191 191 25 28
ZOLPIDEM TARTRATE 191 172 25 14
RANITIDINE HCL 187 187 27 29
TRAMADOL HCL 186 180 28 22
GABAPENTIN 183 164 29 17
ISOSORBIDE MONONITRATE ER 183 179 29 56
HYDROCHLOROTHIAZIDE 176 176 31 9
ATORVASTATIN CALCIUM 174 171 32 13
CLOPIDOGREL 159 158 33 26
FINASTERIDE 146 146 34 66
FLUTICASONE PROPIONATE 141 126 35 32
CITALOPRAM HBR 139 138 36 25
KLOR-CON M20 138 137 37 121
VERAPAMIL ER 136 136 38 99
DIOVAN 136 136 38 40
LOSARTAN POTASSIUM 134 134 40 11
ALENDRONATE SODIUM 132 132 41 23
METOPROLOL SUCCINATE 130 122 42 18
JANTOVEN 126 126 43 140
KLOR-CON 10 121 121 44 106
PLAVIX 115 107 45 39
LORAZEPAM 114 114 46 73
AMIODARONE HCL 112 111 47 211
CIPROFLOXACIN HCL 106 99 48 53
PAROXETINE HCL 106 99 48 60
NIFEDIAC CC 104 104 50 325
GLIPIZIDE 103 103 51 41
CRESTOR 100 83 52 19
TERAZOSIN HCL 100 100 52 103
MECLIZINE HCL 98 98 54 85
LANTUS 97 85 55 59
NITROGLYCERIN PATCH 88 88 56 203
PANTOPRAZOLE SODIUM 87 83 57 38
SPIRONOLACTONE 85 81 58 77
ENALAPRIL MALEATE 83 73 59 35
OXYBUTYNIN CHLORIDE ER 82 82 60 169
ADVAIR DISKUS 78 78 61 52
IBUPROFEN 76 68 62 55
CLOTRIMAZOLE-BETAMETHASONE 76 69 62 84
GLIPIZIDE ER 75 75 64 112
SYNTHROID 73 73 65 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 67 66 110
KLOR-CON M10 71 71 66 227
PREDNISONE 65 65 68 43
INSULIN SYRINGE 64 64 69 76
DOXAZOSIN MESYLATE 63 63 70 57
GEMFIBROZIL 62 62 71 82
PROAIR HFA 62 56 71 62
BENAZEPRIL HCL 60 59 73 71
BUMETANIDE 60 58 73 134
FAMOTIDINE 59 59 75 61
HYDRALAZINE HCL 56 56 76 81
CAPTOPRIL 54 54 77 193
NAMENDA 52 52 78 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 52 78 36
DILTIAZEM ER 51 49 80 167
FLUOXETINE HCL 51 45 80 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.